Select Your Region
LACTEL® 50:50 DL-PLGE, IV 0.26-0.54 is a specialized lactide-glycolide-containing copolymer available as a white to tan pelletized solid with an inherent viscosity of 0.26─0.54 dL/g in HFIP and a degradation time of 3 months max. It contains no added preservatives and may be used for parenteral controlled release applications in pharmaceutical systems.
LACTEL® 50:50 DL-PLGE, IV 0.26-0.54 is an unpurified bioresorbable polymer that offers a cost-effective excipient solution for controlled drug release systems in pharmaceutical and medical applications. Its balanced 50:50 composition of glycolide and d,l-lactide is naturally metabolized by the body and offers a unique degradation profile of 3 months maximum.
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.26─0.54 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry: Poly(DL-lactide-co-glycolide)
Human generic drug formulations Long-acting injectable formulations Price sensitive applications veterinary medicine
Your document download will begin shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you for your inquiry and interest in ChemPoint.
We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you for your inquiry and interest in ChemPoint.
We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
The document currently is provided in the following languages from the supplier at this time.
The document currently is provided in the following languages from the supplier at this time.
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States